208. The combined impact of HLA and non-HLA mismatch between donors and recipients on kidney transplant survival: a genomic analysis in a prospective cohort. EBioMedicine. 2026 Sep;131:106420 (IF 11.2)

Kammer M, Heinzel A, Shoebridge S, Reindl-Schwaighofer R, Hu K, Chen HS, Kainz A, Daoudi I, David AF, Fischer G, Keating B, Niemann M, Oberbauer R; iGeneTRAiN consortium.

207. Human and mouse adrenal glands are characterized by species-specific steroidogenic states and tissue turnover. Nat Genet. 2026; 58(9):2270-2283 (IF 25.5)

Kastriti ME, Maksimov D, Krupinova J, Utkina M, Beltsevich D, Roslyakova A, Glazova O, Kaziakhmedova S, Ryabova A, Kuznetsova A, Shcherbakova A, Bondarenko E, Antysheva Z, Albert E, Urusova L, Lapshina A, Chevais A, Avsievich E, Trofimov V, Melnichenko G, Mokrysheva N, Dedov I, Englmaier L, Petersen J, Gusev O, Heinzel A, Oberbauer R, Volchkov P, Kharchenko PV, Adameyko I.

206. Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation. Sci Transl Med. 2026 (in press) (IF 15.6)

Wekerle T, Muckenhuber M, Heinzel A, Weijler AM, David AF, Kainz V, Hu K, Mucha J, Mengrelis K, Reindl-Schwaighofer R, Böhmig GA, Watschinger B, Györi G, Soliman T, Salat A, Schwarz C, Muhm M, Heinze G, Wolzt M, Worel N, Fortschegger M, Lion T, Regele H, Berlakovich G, Halloran PF, Edinger M, Oberbauer R.

205. Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial. ESC Heart Fail 2026, 13(3):xvag104. (IF 3.7)

Zelniker TA, Paschen C, Mann C, Eigner M, Hafner-Gießauf H, Kletzmayr J, Lorenz M, Ludvik B, Stulnig T, Waller I, Werzowa J, Hödlmoser S, Hengstenberg C, Oberbauer R, Hecking M.

204. Donor-reactive clonotypes are overrepresented in the urinary T-cell repertoire during kidney transplant rejection and show distinct dynamics in the circulation. Am J Transplant 2026 (in press) (IF 8.9)

Aschauer C, Heinzel A, Hu K, Chen HS, Reindl-Schwaighofer R, Wekerle T, Sykes M, David AF, Oberbauer R.

202. DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity. Transpl Int. 2026;38:15601. (IF 2.7)

Eskandary F, Körmöczi GF, Schönbacher M, Fischer G, Faé I, Wenda S, Koren D, Oberbauer R, Reindl-Schwaighofer R, Heinzel A, Kläger J, Kozakowski N, Segerer S, Doberer K, Hidalgo LG, Schachner H, Böhmig GA, Regele H.

SCIENTIFIC COLLABORATIONS